Suppr超能文献

肿瘤血供阻断后经皮射频热消融治疗不可切除肝细胞癌

Percutaneous radio-frequency thermal ablation of nonresectable hepatocellular carcinoma after occlusion of tumor blood supply.

作者信息

Rossi S, Garbagnati F, Lencioni R, Allgaier H P, Marchianò A, Fornari F, Quaretti P, Tolla G D, Ambrosi C, Mazzaferro V, Blum H E, Bartolozzi C

机构信息

Depts of Gastroenterology, Emergency Medicine, and Radiology, Public Hospital of Piacenza, Italy.

出版信息

Radiology. 2000 Oct;217(1):119-26. doi: 10.1148/radiology.217.1.r00se02119.

Abstract

PURPOSE

To evaluate the usefulness of percutaneous radio-frequency (RF) thermal ablation of nonresectable hepatocellular carcinoma (HCC) after occlusion of the tumor arterial supply.

MATERIALS AND METHODS

Sixty-two patients with cirrhosis and biopsy-proved HCC underwent RF ablation after interruption of the tumor arterial supply by means of occlusion of either the hepatic artery with a balloon catheter (40 patients) or the feeding arteries with gelatin sponge particles (22 patients).

RESULTS

After a single RF procedure in 56 patients and after two procedures in six patients, spiral computed tomography (CT) demonstrated a nonenhancing area corresponding in shape to the previously identified HCC, which was suggestive of complete necrosis. No major complications occurred. Two patients subsequently underwent surgical resection; the remaining 60 patients were followed up with spiral CT. During a mean follow-up of 12.1 months, 11 HCC nodules showed areas of local progression; 49 were identified as nonenhancing areas with a 40%-75% reduction in maximum diameter. The 1-year estimate of failure risk was 19% for local recurrence and 45% for overall intrahepatic recurrence. The estimated 1-year survival was 87%. Histopathologic analysis of one autopsy and two surgical specimens revealed more than 90% necrosis in one specimen and 100% necrosis in two.

CONCLUSION

HCC nodules 3.5-8.5 cm in diameter can be ablated in one or two RF sessions after occlusion of the tumor arterial supply.

摘要

目的

评估在阻断肿瘤动脉供血后,经皮射频(RF)热消融不可切除肝细胞癌(HCC)的有效性。

材料与方法

62例经活检证实为HCC的肝硬化患者,在通过球囊导管阻断肝动脉(40例患者)或用明胶海绵颗粒阻断供血动脉(22例患者)中断肿瘤动脉供血后,接受了RF消融。

结果

56例患者接受单次RF治疗,6例患者接受两次治疗后,螺旋计算机断层扫描(CT)显示出一个无强化区域,其形状与先前确定的HCC相对应,提示完全坏死。未发生重大并发症。2例患者随后接受了手术切除;其余60例患者接受螺旋CT随访。在平均12.1个月的随访期间,11个HCC结节出现局部进展区域;49个被确定为无强化区域,最大直径缩小了40%-75%。局部复发的1年失败风险估计为19%,肝内总体复发的风险为45%。估计1年生存率为87%。对1例尸检标本和2例手术标本的组织病理学分析显示,1个标本坏死率超过90%,2个标本坏死率为100%。

结论

在阻断肿瘤动脉供血后,直径3.5-8.5 cm的HCC结节可在一或两次RF治疗中被消融。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验